0001185185-17-002033.txt : 20170920 0001185185-17-002033.hdr.sgml : 20170920 20170920120712 ACCESSION NUMBER: 0001185185-17-002033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170918 FILED AS OF DATE: 20170920 DATE AS OF CHANGE: 20170920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DODD DAVID A CENTRAL INDEX KEY: 0001193607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 002-93277-D FILM NUMBER: 171093610 MAIL ADDRESS: STREET 1: C/O SEROLOGICALS CORP STREET 2: 5565 SPALDING DR CITY: NORCROSS STATE: GA ZIP: 30092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC CENTRAL INDEX KEY: 0000753772 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870412648 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 EAST MICHIGAN AVENUE STREET 2: SUITE 500 CITY: KALAMAZOO STATE: MI ZIP: 49007 BUSINESS PHONE: (269) 202-5020 MAIL ADDRESS: STREET 1: 350 EAST MICHIGAN AVENUE STREET 2: SUITE 500 CITY: KALAMAZOO STATE: MI ZIP: 49007 FORMER COMPANY: FORMER CONFORMED NAME: MADISON FUNDING INC DATE OF NAME CHANGE: 19860413 4 1 form4-dodd091917.xml OWNERSHIP DOCUMENT X0306 4 2017-09-18 0 0000753772 MEDIZONE INTERNATIONAL INC MZEI 0001193607 DODD DAVID A 350 E. MICHIGAN AVE, STE 500 KALAMAZOO MI 49007 1 1 0 0 Chief Executive Officer Common stock 2017-09-18 4 A 0 1000000 0.00 A 1000000 D Mr. Dodd received the stock upon appointment as Chief Executive Officer of the Company. The restricted stock will vest upon six months from the date of grant. /s/ David A. Dodd 2017-09-20